CPDR Patents

cpdr patent banner

CPDR issued U.S. Patents

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations

U.S.: Patent serial #12/444,903. Claims for EPC-1 and 2 issued September 2013.

Complete Document

 

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations

Australia: Patent # 2007324128 has issued ERG-8 claims in January 2014.

Complete Document

 

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations

Japan: Patent # 5470041, has issued ERG-8 in February 2014.

 

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations

European Union: EPC-1 issued, serial # 12163605.4.

 

ERG Monoclonal Antibodies 

U.S.: Patent serial # 13/266,908, notice of allowance to issue with claims that cover sequences specifically for 9FY Ab.

Complete Document

 

ERG Monoclonal Antibodies

European Union: Serial # 10770245.8 with broad claims to a monoclonal Ab that binds to the ERG epitope from 42-66.

 

Androgen-regulated PMEPA1 gene and polypeptides

U.S. Patent serial #7,537,896

Complete Document

 

Prostate-Specific Gene, PCGEM1, and the Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer

U.S. Patent serial #6,828,429

Complete Document

 

Androgen-Regulated Gene Expressed in Prostate Tissue

U.S. Patent serial #6,566,130

Complete Document

 

 

Published U.S. Patent Applications:

 

Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer

Complete Document

 

Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations

Complete Document

 

Androgen-Regulated PMEPA1 Gene and Polypeptides

Complete Document

 

Prostate-Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer

Complete Document

 

Method of Detecting Androgen-Regulated Gene

Complete Document

 

Enhanced Diagnostic Potential of Prostate-Specific Antigen Expressing Cells

Complete Document

 

 

Published PCT Applications:

 

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations

Complete Document

 

Prostate-Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer

Complete Document

 

Enhanced Diagnostic Potential of Prostate-Specific Antigen Expressing Cells*

Complete Document

 

Androgen-Regulated PMEPA1 and Cancer

Complete Document